PMID 12086562
In various rodent models of injury, such as tendon transection, ligament damage, and muscle contusion, researchers have investigated the effects of BPC-157 administration on healing outcomes
Gut Health / Pain / Injury
Handle gently : Avoid vigorous shaking or dropping the solution, as this can destabilize it
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
That has been true for retatrutide as well, according to recent study results